Kenneth E. McMartin, PhD, Professor of Pharmacology, Toxicology & Neuroscience, received the American Academy of Clinical Toxicology (AACT) Distinguished Service Award at the North American Congress of Clinical Toxicology (NACCT) meeting in Chicago on October 26, 2018. This award recognizes Dr. McMartin as an individual who has performed outstanding and dedicated work on behalf of the AACT and the field of clinical toxicology. Past recipients represent the leaders in the field of toxicology and have helped shape AACT to where it is today. Specific recognition was given to Dr. McMartin for his service on the AACT Board of Trustees from 2010-16 and as Chair of the AACT Research Awards Committee from 2010 to now. He has also served as a member of the AACT Scientific Research Committee and the Multi-Center Research Study Review Committee.
He has been the AACT member of the Senior Editorial Board of the journal Clinical Toxicology since 2012. At NACCT, he received the Best Scientific Paper Award in 1998 and the Informa Outstanding Innovation Award (Best presentation) in 2011. His research efforts have emphasized the clinical aspects of toxicology, especially his work that led to the discovery and development of fomepizole, which is now the standard of care antidote for the treatment of methanol and ethylene glycol poisonings. His current research aims to determine the mechanism of toxicity of diglycolic acid, the toxic metabolite of diethylene glycol (DEG), with a goal of finding treatments for these difficult-to-treat DEG poisonings. For such research, he received the Kenneth Morgareidge Award in Toxicology from the International Life Sciences Institute in 1988 and the Translational Impact Award from the Society of Toxicology in 2010. He is currently chair of the Board of Scientific Counselors of the National Toxicology Program of NIEHS.